Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 2
2011 1
2014 3
2015 3
2016 3
2017 3
2019 1
2020 3
2021 3
2022 3
2023 3
2024 4
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

31 results

Results by year

Filters applied: . Clear all
Page 1
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
Neal B, Perkovic V, Mahaffey KW, de Zeeuw D, Fulcher G, Erondu N, Shaw W, Law G, Desai M, Matthews DR; CANVAS Program Collaborative Group. Neal B, et al. N Engl J Med. 2017 Aug 17;377(7):644-657. doi: 10.1056/NEJMoa1611925. Epub 2017 Jun 12. N Engl J Med. 2017. PMID: 28605608 Free article. Clinical Trial.
Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial.
Fleischmann R, Mysler E, Hall S, Kivitz AJ, Moots RJ, Luo Z, DeMasi R, Soma K, Zhang R, Takiya L, Tatulych S, Mojcik C, Krishnaswami S, Menon S, Smolen JS; ORAL Strategy investigators. Fleischmann R, et al. Lancet. 2017 Jul 29;390(10093):457-468. doi: 10.1016/S0140-6736(17)31618-5. Epub 2017 Jun 16. Lancet. 2017. PMID: 28629665 Clinical Trial.
EPOCHA-AH 1998–2017. Dynamics of prevalence, awareness of arterial hypertension, treatment coverage, and effective control of blood pressure in the European part of the Russian Federation.
Badin YV, Fomin IV, Belenkov YN, Mareev VY, Ageev FT, Polyakov DS, Artemjeva EG, Galyavich AS, Ionova TS, Kamalov GM, Kechedzhieva SG, Koziolova NA, Malenkova VY, Malchikova SV, Smirnova EA, Tarlovskaya EI, Shechrbinina EV, Valikulova FY, Vaysberg AR, Yakushin SS. Badin YV, et al. Among authors: yakushin ss. Kardiologiia. 2019 Jan 31;59(1S):34-42. doi: 10.18087/cardio.2445. Kardiologiia. 2019. PMID: 30706837 Russian.
[EPOCH-CHF As A Mirror of the Current Problems in Cardiovascular Diseases Treatment in Real Clinical Practice].
Fomin IV, Belenkov YN, Mareev VY, Ageev FT, Artemyeva EG, Badin YV, Bakulina EV, Weisberg AR, Vinogradova NG, Galyavich AS, Ionova TS, Kamalov GM, Kechedzhieva SG, Koziolova NA, Malenkova VY, Malchikova SV, Polyakov DS, Smirnova EA, Tarlovskaya EI, Shcherbinina EV, Yakushin SS. Fomin IV, et al. Among authors: yakushin ss. Kardiologiia. 2024 Nov 30;64(11):48-61. doi: 10.18087/cardio.2024.11.n2808. Kardiologiia. 2024. PMID: 39637391 Russian.
[Iron deficiency in Russia heart failure patients. Observational cross-sectional multicenter study].
Mareev VY, Begrambekova YL, Mareev YV, Kobalava ZD, Karapetyan LV, Galochkin SA, Kazakhmedov ER, Lapshin AA, Garganeeva AA, Kuzheleva EA, Efremushkina AА, Kiseleva EV, Barbarash OL, Pecherina TB, Galyavich AS, Galeeva ZM, Baleeva LV, Koziolova NA, Veklich AS, Duplyakov DV, Maksimova MN, Yakushin SS, Smirnova EA, Sedykh EV, Shaposhnik II, Makarova NA, Zemlyanukhina AA, Skibitsky VV, Fendrikova AV, Skibitsky AV, Spiropulos NA, Seredenina EM, Orlova YA, Eruslanova KA, Kotovskaya YV, Tkacheva ON, Fedin MA. Mareev VY, et al. Among authors: yakushin ss. Kardiologiia. 2022 May 31;62(5):4-8. doi: 10.18087/cardio.2022.5.n2083. Kardiologiia. 2022. PMID: 35692168 Russian.
Female and Male Phenotypes of Iron Deficiency in CHF. Additional analysis of the «The Prevalence of Iron Deficiency in Patients With Chronic Heart Failure in the Russian Federation (J-CHF-RF)» study.
Begrambekova YL, Mareev YV, Mareev VY, Orlova YA, Kobalava ZD, Karapetyan LV, Galochkin SA, Kazakhmedov ER, Lapshin AA, Garganeeva AA, Kuzheleva EA, Efremushkina AA, Kiseleva EV, Barbarash OL, Pecherina TB, Galyavich AS, Galeeva ZM, Baleeva LV, Koziolova NA, Veclich AS, Duplyakov DV, Maksimova MN, Yakushin SS, Smirnova EA, Sedykh EV, Shaposhnik II, Makarova NA, Zemlyanukhina AA, Skibitsky VV, Fendrikova AV, Skibitsky AV, Spiropoulos NA, Seredenina EM, Eruslanova KA, Kotovskaya YV, Tkacheva ON, Fedin MA. Begrambekova YL, et al. Among authors: yakushin ss. Kardiologiia. 2023 Sep 30;63(9):3-13. doi: 10.18087/cardio.2023.9.n2413. Kardiologiia. 2023. PMID: 37815134 English, Russian.
[Empagliflozin and heart failure: position paper of the experts on the results of the online meeting and discussion of the EMPEROR-Preserved Trial].
Arutyunov GP, Lopatin YM, Ametov AS, Ageev FT, Antsiferov MB, Villevalde SV, Vinogradova NG, Galstyan GR, Galyavich AS, Gilyarevskiy SR, Glezer MG, Zhirov IV, Ilyin MV, Lebedeva AI, Nedogoda SM, Salukhov VV, Tarlovskaya EI, Tereshchenko SN, Fomin IV, Khalimov IS, Khasanov NR, Cherkashin DV, Yakushin SS. Arutyunov GP, et al. Among authors: yakushin ss. Ter Arkh. 2021 Dec 15;93(12):1491-1497. doi: 10.26442/00403660.2021.12.201281. Ter Arkh. 2021. PMID: 36286678 Russian.
31 results